Acute myocardial infarction (AMI) has a high mortality rate and poor prognosis for patients. The primary causes of death are arrhythmia and heart failure. For patients admitted because of myocardial infarction, various risk evaluations are initiated to foresee possible complications. The thrombolysis in myocardial infarction (TIMI) risk score, which can be used to predict the prognosis and the need for revascularisation, is the most convenient and commonly used system, but is inadequate for AMI patients on admittance. Fragmented QRS (fQRS) has been shown to be a valuable electrocardiographic (ECG) index for predicting the prognosis of patients with coronary heart disease (Das et al., 2006 (Das et al., , 2007 . Also, fQRS is considered to predict an increased likelihood of a poor outcome and mortality in patients with coronary artery disease (CAD) (Güngör et al., 2016) , even for some successfully revascularized AMI patients (Tanriverdi et al., 2017; Zhang et al., 2017) . So what would happen if fQRS and the TIMI risk score were combined? This study focused on the investigation of the short-term prognostic value of fQRS combined with the TIMI risk score for patients with AMI.
Three hundred patients with AMI under continuous treatment in the coronary care unit (CCU) and general wards were selected for this study. Patients with severe valvular disease, congenital heart disease or pacemaker implantation, or other severe organ disease or dysfunction such as cancer, liver or kidney failure, neuro or mental disease, were excluded. Seven clinical variables were used to determine the TIMI risk score, each adding a value of 1 point if present (Antman et al., 2000) : (1) age >65 years, (2) ≥3 classical risk factors for CAD, (3) known CAD, (4) use of aspirin in the past 7 d, (5) severe angina in the past 24 h, (6) elevated cardiac markers, (7) STdeviation ≥0.5 mm.
A serial 12-lead ECG (filter range, 0.5-100.0 Hz; AC filter, 25 mm/s, 10 mm/mV) was performed right after the patients were admitted to hospital and rechecked after 1, 3, 6, 12, 24 h, and every day after a percutaneous coronary intervention (PCI) until they were discharged or died. ECG monitoring was required upon admission as well as Holter electrocardiogram and echocardiography on the third day after admission. Any fQRS detected was deemed to be positive fQRS, regardless of how many leads were involved or on which days it appeared. Patients with a left ventricular ejection fraction <40% were deemed to have left ventricular systolic dysfunction (LVSD). Malignant cardiac arrhythmia included polymorphic ventricular extrasystoles, ventricular tachycardia, and ventricular fibrillation. The secondary observation endpoint involved more than one cardiac incident, including cardiac arrest, malignant ventricular arrhythmia, and acute heart failure. Patient evaluation would end with either discharge after recovery or all-cause death. The Student's t-test was used for comparison of averages and the chi-square test for comparison of rates. A 95% confidence interval (CI) of relative risk (RR) was taken as suggesting the presence of a clinically significant risk factor. A P-value of <0.05 was taken to indicate statistical significance.
Diagnostic standards for fQRS are shown as follows (Das et al., 2006 (Das et al., , 2007 : (1) Narrow fQRS: new or different morphological triphasic QRS waves in the regular 12-lead ECG (RSR' type) or multiphasic waves, with or without a Q-wave in two or more corresponding leads of the coronary arterial branch, except for the complete (QRS ≥120 ms) or incomplete bundle branch block and intraventricular block; (2) Wide fQRS (f-wQRS): for a wide QRS wave of bundle branch block (QRS >120 ms), an R-wave or S-wave with more than two notches in two sequential leads was observed (f-LBBB QRS, f-RBBB QRS); for a wide QRS complex of premature ventricular contractions (PVCs), R-waves showed two notches and time intervals greater than 40 ms between the two notches of the QRS waves in two or more sequential leads (fragmented PVCs). Electrocardiograms were compared with previous electrocardiograms if available, to confirm fQRS or that pathologic Q waves were the result of a new onset. The different sorts of fQRS are shown in Fig. 1 .
The 300 patients included 204 males and 96 females with an average age of (68.48±0.71) years. Two hundred and one patients had NSTEMI and the remaining 99 had STEMI according to the discharge diagnosis. During hospitalization, 184 patients received PCI treatment, while the remaining 116 patients received a conservative treatment plan including dual-antiplatelet, anticoagulation with low molecular weight heparin, statins, and nitrates, β blockers, angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB), which were given based on the condition of the patients and whether they had complications. One hundred and sixty-nine patients were found to have fQRS. There were no significant differences in comparison of age, sex, and location of infarct between the groups with or without fQRS (Table 1) .
Although the TIMI score was first used for NSTEMI rather than STEMI (Antman et al., 2000) , we found that the categories in the score could apply to both NSTEMI and STEMI. Sometimes it might take hours for the patient to develop the characteristics of certain ST, whether elevate or deviate, and it could be hard to distinguish NSTEMI from STEMI patients following admission. Therefore, we used this TIMI score to initially grade patients with AMI. The same situation may apply to many other clinical scoring systems that could be used initially under different circumstances. By using the TIMI score and fQRS, the sensitivity and specificity for the prediction of malignant cardiac arrhythmia were 50.0% and 91.1%, and for the detection of LVSD were 60.9% and 84.1%, respectively. When using the TIMI score alone, the sensitivity and specificity were, respectively, 23.3% and 88.6% for the prediction of mortality, 23.4% and 74.3% for the prediction of LVSD, and 30.5% and 79.6% for the prediction of malignant cardiac arrhythmia. In the combined analysis for the group with a TIMI risk score of ≥4 and the group with a TIMI risk score of <4, both of which had positive fQRS, the group with the score of ≥4 had a much higher incidence of LVSD, and the rate was three times that of the non-fQRS group (P<0.05). From the group with a TIMI risk score of <4, we could see that in combination with the presence of fQRS, the numbers of cases with malignant cardiac arrhythmia, LVSD, and mortality were all significantly higher than those observed in the negative fQRS group.
As there was no report of malignant cardiac arrhythmia in patients of negative fQRS, the specificity was therefore 100.0%. The incidence of LVSD was four times that of the non-fQRS group (P=0.065), and the mortality rate was nine times higher (P=0.014; Table 2 ). Positive fQRS patients were first grouped by TIMI risk score and then by the treatment they received (either with or without PCI), before they were all evaluated for the conditions of malignant cardiac arrhythmia, LVSD, or mortality. In the group with a TIMI risk score of ≥4, the incidence rates of LVSD and mortality were significantly higher in patients without PCI (Table 3 ). This effect was even more pronounced in the number of deaths (P<0.01). In the group with a TIMI risk score of <4, significant differences were seen in the rates of malignant cardiac arrhythmia and mortality for patients without PCI treatment. The mortality rate was dramatically increased (P<0.01).
Many studies have shown the important clinical value of risk stratification and prognosis for patients of AMI. The TIMI risk score was established as an evaluative method by two triphase international experiments with random and double-blinded design for prognosis of coronary heart disease. However, discrepancies between the predictions and the actual outcomes for patients were always observed in clinical settings, because the method focused mainly on immediate evaluation of each patient's condition upon admission and the need for any emergency PCI treatment, and was less able to provide valuable information for short-term prognosis of hospitalized patients. Das et al. (2009) conducted follow-up for 5.5 years on 998 patients with acute coronary syndrome and found that the mortality rates for an fQRS group and a non-fQRS group were 34% and 26%, respectively, and that positive fQRS was the significant independent predictive factor for acute coronary Data are expressed as number (percentage) of patients syndrome. The relationship between fQRS and the scoring system in patients with acute coronary syndrome was also reported (Bekler et al., 2015) . Therefore, we used fQRS combined with the TIMI risk score to evaluate changes in condition and the prognostic outcomes for patients with AMI during hospitalization. With the combination of fQRS and the TIMI risk score, we concluded that the test had higher sensitivity and specificity in predicting the chance of malignant cardiac arrhythmia, LVSD, or death. In the group with a TIMI risk score of <4, we could see that in combination with the presence of fQRS, the numbers of cases with malignant cardiac arrhythmia, LVSD, and mortality were all significantly higher than those in the negative fQRS group. A study of changes in connexin protein 43, intracellular calcium concentration, and the apoptotic process of ischemic myocardiocytes (Wang and Zhao, 2011) showed a relationship between early ventricular arrhythmia and an increase in calcium concentration that led to apoptosis during the acute phase of infarction. During myocardial ischemia, the conduction velocity of cells, including the surrounding normal myocardiocytes, decreased. A progressive gradient of rearrangement and destruction in connexins from non-ischemic to ischemic regions was observed (Liu et al., 2010) . The concentration of connexins in the surrounding region of ischemia was much lower than the concentration between normal cells, thereby creating an inconsistent conduction velocity across the regions. As a result, the electrophysiological activity of myocardiocytes became asynchronous. Abnormal electrophysiological activity and slow conduction in ischemic myocardiocytes would usually generate a multiple notched QRS complex with low amplitude, known as fQRS. Morita et al. (2008) pointed out that fQRS existed in nearly 40% of patients with Brugada syndrome and was often observed in patients who had ventricular fibrillation episodes. The preferential occurrence of fQRS in the right precordial leads, especially in the higher intercostal spaces, corresponded to a localized conduction abnormality in the right ventricular outflow tract. The generation of multiple spike waves in fQRS was also seen in patients with Brugada syndrome who carried a defective gene SCN5A, which manifested as reduced conduction at multiple locations and would eventually lead to cardiac arrhythmia. This phenomenon could be used to predict the incidence of ventricular fibrillation, and the presence of fQRS was often used as a warning sign for high incidence of sudden cardiac arrest. Furthermore, the presence of fQRS in a different lead may also predict the severity of CAD (El-Dosouky and Abomandour, 2017; Eyuboglu et al., 2017) . To understand the correlation between PCI treatment and the short-term prognostic value of fQRS with the TIMI risk score, our study indicated that regardless of the TIMI risk score, patients with fQRS without PCI treatment would have a significantly higher mortality rate. A TIMI risk score of <4 points would be classified as medium risk and would usually lead to conservative medication as treatment if there were no signs of hemodynamic disturbance, frequent chest pain or changes in ECG. From our study, patients with a TIMI risk score of <4 would have a poor short-term prognosis when there are signs of fQRS. We showed that early PCI treatment could, to some degree, improve the condition and prevent malignant cardiac arrhythmia, LVSD, or even death. In addition, logistic regression analysis showed that malignant cardiac arrhythmia and fQRS were the independent predictive factors for increased mortality rate during hospitalization, while the TIMI score was not influential. Therefore, the combination of the TIMI risk score and fQRS in clinical practice can provide complete and objective prognostic evaluation of AMI patients. It plays a key role in instructing physicians to prescribe sufficient anti-coagulation treatment or intervention for patients with a score of <4. As a result, the mortality rate and the duration of hospitalization can be reduced, allowing the hospital to apply appropriate medical resources based on the risk to patients.
We have demonstrated the relationship between fQRS and short-term prognosis of patients with AMI (Sheng et al., 2014) . Further studies showed that fQRS combined with the TIMI risk score could increase the sensitivity and specificity of the prognosis in AMI patients. For AMI patients with positive fQRS who undergo early revascularization, the incidence of cardiovascular events could be reduced. Moreover, the presence of fQRS could be used as an indicator for early intervention treatment in patients with a TIMI score of <4.
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